Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Specialty Chemicals segment offers specialty ingredients, fine chemicals, crop protection chemicals, and custom development and manufacturing services. The Nutrition & Health Solutions segment provides nutrition and health ingredients, animal nutrition and health solutions, and human nutrition and health solutions. The Life Science Chemicals offers life science ingredients and specialty ethanol. The company also offers pyridine and picolines, cyanopyridines, piperidines, acetyl pyridines, amino pyridines, halo pyridines, pyridine aldehydes, metal complexes, amino pyridines, halogenated pyridines, quaternary salts, alkyl pyridines, vitamin B3 and picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, absolute alcohol, ethanol, biocompost, CO2 and ETO mixtures. In addition, it provides route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company offers vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, nutrition, agrochemical, consumer, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is based in Noida, India.
Jubilant Ingrevia Dividend Announcement
• Jubilant Ingrevia announced a semi annually dividend of ₹2.50 per ordinary share which will be made payable on 2024-09-29. Ex dividend date: 2024-08-02
• Jubilant Ingrevia annual dividend for 2024 was ₹5.00
• Jubilant Ingrevia annual dividend for 2023 was ₹5.00
• Jubilant Ingrevia's trailing twelve-month (TTM) dividend yield is 0.72%
Jubilant Ingrevia Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-08-02 | ₹2.50 | semi annually | 2024-09-29 |
2024-02-09 | ₹2.50 | semi annually | 2024-02-28 |
2023-08-10 | ₹2.50 | semi annually | 2023-09-30 |
2023-02-10 | ₹2.50 | semi annually | 2023-03-01 |
2022-08-23 | ₹2.50 | semi annually | 2022-10-24 |
2022-02-10 | ₹2.50 | semi annually | 2022-03-02 |
2021-08-05 | ₹0.35 | semi annually | 2021-10-20 |
Jubilant Ingrevia Dividend per year
Jubilant Ingrevia Dividend growth
Jubilant Ingrevia Dividend Yield
Jubilant Ingrevia current trailing twelve-month (TTM) dividend yield is 0.72%. Interested in purchasing Jubilant Ingrevia stock? Use our calculator to estimate your expected dividend yield:
Jubilant Ingrevia Financial Ratios
Jubilant Ingrevia Dividend FAQ
Other factors to consider when evaluating Jubilant Ingrevia as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Jubilant Ingrevia stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Jubilant Ingrevia's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Jubilant Ingrevia publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Jubilant Ingrevia distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Jubilant Ingrevia are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Jubilant Ingrevia sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Jubilant Ingrevia distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Jubilant Ingrevia declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Jubilant Ingrevia's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Jubilant Ingrevia's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.